{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-22-130714","form_type":"8-K","ticker":"OTLK","cik":"0001649989","company_name":"Outlook Therapeutics, Inc.","filed_at":"2022-12-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.574909+00:00","generated_at":"2026-06-20T21:53:56.458177+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Outlook Therapeutics reports FY2022 net loss $66.1M; raises ~$55M; PDUFA date Aug 29, 2023","bullets":["Net loss $66.1M ($0.31/sh) for FY2022 vs $53.2M ($0.35/sh) in FY2021.","Cash and equivalents $17.4M at Sept 30, 2022; subsequent financings raised ~$55M gross.","FDA accepted BLA for ONS-5010; PDUFA goal date set for August 29, 2023.","Entered strategic commercialization agreement with AmerisourceBergen for 3PL and services.","Appointed Julia Haller, MD to the Board of Directors."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-22-130714","json":"https://secwatch.observer/filing/0001104659-22-130714.json","markdown":"https://secwatch.observer/filing/0001104659-22-130714.md","text":"https://secwatch.observer/filing/0001104659-22-130714.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1649989/000110465922130714/0001104659-22-130714-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1649989/000110465922130714/tm2233528d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T21:53:56.458177+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a64523c49e27577a372f656719d00e70fc3435da","claim":"Outlook Therapeutics, Inc. reported financial results for fiscal year ended September 30, 2022.","evidence_excerpt":"On December 29, 2022, Outlook Therapeutics, Inc. (the “Company”) issued a press release announcing its financial results for its fourth fiscal quarter and year ended September 30, 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1649989/000110465922130714/0001104659-22-130714-index.htm","confidence":1.0,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year ended September 30, 2022"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}